Saab (SAABY) & Its Competitors Financial Analysis
Saab (OTCMKTS:SAABY – Get Free Report) is one of 229 public companies in the “Aerospace & Defense” industry, but how does it compare to its peers? We will compare Saab to related businesses based on the strength of its institutional ownership, earnings, profitability, risk, valuation, analyst recommendations and dividends. Risk and Volatility Saab has a […]
Financial Analysis: Savers Value Village (SVV) and Its Competitors
Savers Value Village (NYSE:SVV – Get Free Report) is one of 142 publicly-traded companies in the “Broadline Retail” industry, but how does it contrast to its competitors? We will compare Savers Value Village to similar companies based on the strength of its earnings, analyst recommendations, profitability, dividends, valuation, institutional ownership and risk. Analyst Ratings This […]
Financial Analysis: FirstEnergy (FE) & Its Competitors
FirstEnergy (NYSE:FE – Get Free Report) is one of 105 publicly-traded companies in the “Electric Utilities” industry, but how does it contrast to its rivals? We will compare FirstEnergy to related companies based on the strength of its institutional ownership, profitability, analyst recommendations, earnings, valuation, dividends and risk. Insider and Institutional Ownership 89.4% of FirstEnergy […]
Chemung Financial (CHMG) & Its Competitors Head-To-Head Analysis
Chemung Financial (NASDAQ:CHMG – Get Free Report) is one of 919 publicly-traded companies in the “Banks” industry, but how does it compare to its competitors? We will compare Chemung Financial to similar businesses based on the strength of its earnings, risk, institutional ownership, analyst recommendations, profitability, dividends and valuation. Volatility & Risk Chemung Financial has […]
Financial Analysis: Cytokinetics (CYTK) and Its Competitors
Cytokinetics (NASDAQ:CYTK – Get Free Report) is one of 844 public companies in the “Biotechnology” industry, but how does it compare to its rivals? We will compare Cytokinetics to similar businesses based on the strength of its valuation, profitability, institutional ownership, dividends, earnings, analyst recommendations and risk. Earnings and Valuation This table compares Cytokinetics and […]
Pyxis Oncology (PYXS) & Its Competitors Financial Analysis
Pyxis Oncology (NASDAQ:PYXS – Get Free Report) is one of 844 public companies in the “Biotechnology” industry, but how does it weigh in compared to its peers? We will compare Pyxis Oncology to related companies based on the strength of its profitability, analyst recommendations, valuation, risk, earnings, dividends and institutional ownership. Volatility and Risk Pyxis […]
last updated on 11 Nov 21:52